Aspen Aerogels, Inc.
ASPN
$5.79
$0.325.85%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -47.30% | -40.11% | -14.74% | 11.18% | 51.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.30% | -40.11% | -14.74% | 11.18% | 51.90% |
| Cost of Revenue | 104.70% | 105.28% | -1,675.70% | -1,818.85% | -2,041.95% |
| Gross Profit | -98.82% | -98.39% | 2,399.17% | 3,080.16% | 4,629.23% |
| SG&A Expenses | -17.71% | -21.37% | -13.74% | -4.43% | 7.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.44% | 108.08% | -1,125.11% | -1,191.33% | -1,299.37% |
| Operating Income | -101.11% | -100.69% | 8,608.73% | 27,121.46% | 19,081.84% |
| Income Before Tax | 60.94% | -2,665.83% | -9,055.39% | -10,386.23% | -843.73% |
| Income Tax Expenses | -47.64% | 39.67% | 22.60% | 22.63% | 169.05% |
| Earnings from Continuing Operations | 60.85% | -3,012.54% | -20,533.53% | -22,523.65% | -827.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.85% | -3,012.54% | -20,533.53% | -22,523.65% | -827.19% |
| EBIT | -101.11% | -100.69% | 8,608.73% | 27,121.46% | 19,081.84% |
| EBITDA | -100.56% | -100.13% | 5,902.74% | 11,417.24% | 120,765.11% |
| EPS Basic | 61.05% | -2,948.56% | -20,086.56% | -3,810,800.00% | -685.78% |
| Normalized Basic EPS | -101.35% | -100.89% | 10,390.89% | 73,592.82% | 13,385.96% |
| EPS Diluted | 61.13% | -3,228.69% | -93,227.50% | -23,894.97% | -679.09% |
| Normalized Diluted EPS | -101.39% | -100.91% | 10,294.88% | 80,933.94% | 13,051.99% |
| Average Basic Shares Outstanding | 4.57% | 6.48% | 9.78% | 10.29% | 10.98% |
| Average Diluted Shares Outstanding | 3.02% | 4.87% | 9.51% | 10.01% | 12.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |